Andrew Galler
Stock Analyst at Morgan Stanley
(0.79)
# 3,210
Out of 4,667 analysts
27
Total ratings
33.33%
Success rate
-15.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Overweight | $80 → $74 | $32.42 | +128.25% | 11 | Oct 11, 2024 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $9.59 | +56.41% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $6.93 | +159.74% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $18.71 | +97.76% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $35.40 | +58.19% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $6.74 | +167.06% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $41.96 | +28.69% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $45.76 | +9.27% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $1.98 | +2,122.22% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $36.94 | +722.96% | 1 | Nov 9, 2021 |
Immunocore Holdings
Oct 11, 2024
Maintains: Overweight
Price Target: $80 → $74
Current: $32.42
Upside: +128.25%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $9.59
Upside: +56.41%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $6.93
Upside: +159.74%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $18.71
Upside: +97.76%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $35.40
Upside: +58.19%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $6.74
Upside: +167.06%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $41.96
Upside: +28.69%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $45.76
Upside: +9.27%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $1.98
Upside: +2,122.22%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $36.94
Upside: +722.96%